Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Data from Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
  1. Home
  2. Publications
  3. Data from Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial

Data from Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial

Authors:
  • JXJianming Xu
    Jianming Xu
  • JSJie Shen
    Jie Shen
  • SGShanzhi Gu
    Shanzhi Gu
  • YZYun Zhang
    Yun Zhang
  • LWLihua Wu
    Lihua Wu
  • JWJian Wu
    Jian Wu
  • GSGuoliang Shao
    Guoliang Shao
  • LXLi Xu
    Li Xu
  • TYTao Yin
    Tao Yin
  • JLJingfeng Liu
    Jingfeng Liu
  • ZRZhenggang Ren
    Zhenggang Ren

Open Access
Publisher website
Google Scholar
  • 31 March 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.c.6530222.v1
Abstract
No abstract available
Keywords
  • APATINIB
  • CLINICAL ENDPOINT
  • REFRACTORY (PLANETARY SCIENCE)
  • PROGRESSION-FREE SURVIVAL
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.